Aurobindo Pharma Ltd.’s ANDA 205835 for Meropenem for Injection was approved on 27 Mar. 2017 by US FDA.

meropenem-1g-30ml_v2-webAuroMedics, a subsidiary of Aurobindo, will commence marketing the product in April 2017.